L-R) Stu Needleman, Chief Commercial Officer and Chief Patient Centricity Officer, Piramal Pharma Solutions; Douglas Kling, Chief Operating Officer, NewAmsterdam Pharma; Sheng Cui, Chief Manufacturing Officer, NewAmsterdam Pharma; Mahesh Kulkarni, Ph.D., Senior Director, Drug Product, NewAmsterdam Pharma; Manoj Zalpuri, North American Operations Head, Piramal Pharma Solutions; Ian Smart, Managing Partner, Verta Life Sciences; and Daniel Kloss, Sellersville Site Head, Piramal Pharma Solutions, unveil the dedicated OSD suite at the Sellersville facility.

Piramal and NewAmsterdam Pharma open OSD form suite

HTP Desk - 0
WITT

WITT Gas highlights Oxypad gas analyzer

HTP Desk - 0
pharma

Pharma sector faces tariff threats: Report

HTP Desk - 0
DKMS

DKMS John Hansen Research Grant 2026

HTP Desk - 0
Medkart

How Medkart is Building India’s Smartest Generic Medicine App

HTP Desk - 0
Gerresheimer

Gerresheimer to separate molded glass business

HTP Desk - 0
Fortis

Fortis Hiranandani Vashi launches advanced robotic surgery program

HTP Desk - 0
The findings showed that three two-drug combination therapies – Amlodipine plus Perindopril, Amlodipine plus Indapamide, and Perindopril plus Indapamide – were equally effective and safe in lowering both ambulatory and office blood pressure.

Two-drug therapies effective in improving blood pressure control in Indians

HTP Desk - 0
Ramakrishna

Sri Ramakrishna Hospital Highlights the Urgent Need for Early Treatment of...

HTP Desk - 0
Sleep

Sleep Disorders in Youth Fast Becoming Public Health Crisis

HTP Desk - 0
Load more